Literature DB >> 27438767

MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor.

Huang-Yu Yang1, Joseph Barbi2, Chao-Yi Wu3, Ying Zheng4, Paolo D A Vignali5, Xingmei Wu4, Jin-Hui Tao5, Benjamin V Park5, Shashika Bandara5, Lewis Novack5, Xuhao Ni5, Xiaoping Yang5, Kwang-Yu Chang6, Ren-Chin Wu7, Junran Zhang8, Chih-Wei Yang9, Drew M Pardoll5, Huabin Li10, Fan Pan11.   

Abstract

Regulatory T (Treg) cells are important in maintaining self-tolerance and immune homeostasis. The Treg cell transcription factor Foxp3 works in concert with other co-regulatory molecules, including Eos, to determine the transcriptional signature and characteristic suppressive phenotype of Treg cells. Here, we report that the inflammatory cytokine interleukin-6 (IL-6) actively repressed Eos expression through microRNA-17 (miR-17). miR-17 expression increased in Treg cells in the presence of IL-6, and its expression negatively correlated with that of Eos. Treg cell suppressive activity was diminished upon overexpression of miR-17 in vitro and in vivo, which was mitigated upon co-expression of an Eos mutant lacking miR-17 target sites. Also, RNAi of miR-17 resulted in enhanced suppressive activity. Ectopic expression of miR-17 imparted effector-T-cell-like characteristics to Treg cells via the de-repression of genes encoding effector cytokines. Thus, miR-17 provides a potent layer of Treg cell control through targeting Eos and additional Foxp3 co-regulators.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438767      PMCID: PMC4957244          DOI: 10.1016/j.immuni.2016.06.022

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  55 in total

1.  A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Authors:  H Tagawa; M Seto
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

2.  Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

Authors:  Susan Kohlhaas; Oliver A Garden; Cheryl Scudamore; Martin Turner; Klaus Okkenhaug; Elena Vigorito
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

3.  An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

Authors:  Madhav D Sharma; Lei Huang; Jeong-Hyeon Choi; Eun-Joon Lee; James M Wilson; Henrique Lemos; Fan Pan; Bruce R Blazar; Drew M Pardoll; Andrew L Mellor; Huidong Shi; David H Munn
Journal:  Immunity       Date:  2013-05-16       Impact factor: 31.745

4.  Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.

Authors:  Matthias Brock; Michelle Trenkmann; Renate E Gay; Beat A Michel; Steffen Gay; Manuel Fischler; Silvia Ulrich; Rudolf Speich; Lars C Huber
Journal:  Circ Res       Date:  2009-04-23       Impact factor: 17.367

5.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

6.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.

Authors:  Jaime Darce; Dipayan Rudra; Li Li; Junko Nishio; Daniela Cipolletta; Alexander Y Rudensky; Diane Mathis; Christophe Benoist
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

7.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

8.  Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

Authors:  Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Transcription factor Foxp3 and its protein partners form a complex regulatory network.

Authors:  Dipayan Rudra; Paul deRoos; Ashutosh Chaudhry; Rachel E Niec; Aaron Arvey; Robert M Samstein; Christina Leslie; Scott A Shaffer; David R Goodlett; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

View more
  36 in total

Review 1.  Epigenetic regulation of T helper cells and intestinal pathogenicity.

Authors:  Yuya Hagihara; Yusuke Yoshimatsu; Yohei Mikami; Yoshiaki Takada; Shinta Mizuno; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2019-03-19       Impact factor: 9.623

Review 2.  Pathogenic CD4+ T cells in patients with asthma.

Authors:  Lyndsey M Muehling; Monica G Lawrence; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-04-22       Impact factor: 10.793

Review 3.  IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.

Authors:  David H Munn; Madhav D Sharma; Theodore S Johnson; Paulo Rodriguez
Journal:  Cancer Immunol Immunother       Date:  2017-05-09       Impact factor: 6.968

4.  MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.

Authors:  Yongxia Wu; Steven Schutt; Katelyn Paz; Mengmeng Zhang; Ryan P Flynn; David Bastian; M Hanief Sofi; Hung Nguyen; Min Dai; Chen Liu; Ying-Jun Chang; Bruce R Blazar; Xue-Zhong Yu
Journal:  Blood       Date:  2018-03-12       Impact factor: 22.113

5.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

6.  A Distinct Inhibitory Function for miR-18a in Th17 Cell Differentiation.

Authors:  Misty M Montoya; Julia Maul; Priti B Singh; Heather H Pua; Frank Dahlström; Nanyan Wu; Xiaozhu Huang; K Mark Ansel; Dirk Baumjohann
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

7.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

Review 8.  Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy.

Authors:  David H Munn; Madhav D Sharma; Theodore S Johnson
Journal:  Cancer Res       Date:  2018-09-04       Impact factor: 12.701

Review 9.  Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.

Authors:  Kaitlin A Read; Devin M Jones; Aharon G Freud; Kenneth J Oestreich
Journal:  Immunol Rev       Date:  2020-12-17       Impact factor: 12.988

Review 10.  MicroRNAs: Harbingers and shapers of periodontal inflammation.

Authors:  Xianghong Luan; Xiaofeng Zhou; Pooria Fallah; Mirali Pandya; Huling Lyu; Deborah Foyle; Dan Burch; Thomas G H Diekwisch
Journal:  Semin Cell Dev Biol       Date:  2021-06-10       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.